{
  "name" : "dacemirror.sci-hub.se_journal-article_03d9b2499a4bfbb6fed86c765374834e_tian2018.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "Biofunctional magnetic hybrid nanomaterials for theranostic applications",
    "authors" : [ "Xin Tian", "Shaopeng Liu", "Jianliang Zhu", "Zheyan Qian", "Lei Bai", "Yue Pan" ],
    "emails" : [ "panyueps@gmail.com" ],
    "sections" : [ {
      "heading" : null,
      "text" : "Keywords: magnetic hybrid nanomaterials, multimodal diagnosis, cancer radiation therapy, theranostic\n(Some figures may appear in colour only in the online journal)\n5 These authors contributed equally to this work.\n0957-4484/19/032002+10$33.00 © 2018 IOP Publishing Ltd Printed in the UK1"
    }, {
      "heading" : "1. Introduction",
      "text" : "Cancer is one of the biggest threats to human life and health [1, 2]. To develop an effective and comprehensive treatment strategy to deal with such an important disease, researchers have endeavored to develop diagnostic and therapeutic technologies over the past decades [3, 4]. Early diagnosis, intraoperative localization and postoperative imaging examination are important factors to improve the curative effect of tumor therapy. However, traditional imaging techniques are limited to the observation of tumor tissue after surgery, and there is a certain lag. Therefore, tracking accurate localization of tumors to achieve effective treatment under the guidance of imaging is one of the hot topics in tumor research. Traditional treatments, including surgery, photothermal therapy (PTT), chemotherapy and radiation therapy (RT), have many drawbacks [5]. For example, the non-specific killing effect, the resistance effect in the RT, the cytotoxic effect, and some other side effects from the chemotherapeutic drugs in chemotherapy are always observed. Given this, it is of great significance to explore new therapeutic methods and to integrate their advantages to achieve synergetic medical effectiveness.\nThe emergence of nanotechnology opens up new possibilities to solve the above problems [6–9]. Magnetic nanoparticles possess many unique features, such as high biosafety, easy synthesis and outstanding physicochemical properties [10, 11]. Such characteristics have attracted the attention of researchers to develop a wide variety of multifunctional magnetic nanoparticles for numerous practical medical applications [12–15]. For example, magnetic nanoparticles have been used as imaging contrast agents, radiosensitizers, photothermal treatment agents and so on [16]. However, the magnetic particles composed of single component cannot fully meet the demands of tumor diagnosis and treatment simultaneously. Therefore, there is an urgent need to develop hybrid nanomaterials based on magnetic nanoparticles, enabling greater multifunctionality to be achieved. Recently, magnetic hybrid nanoparticles (MHNs) have been extensively developed and regarded as promising candidates to overcome the difficulties encountered in the tumor treatment so far.\nThis innovative material incorporates diverse functional components into one entity, therefore integrates all different advantages of composing materials to make it a nearly flawless hybrid material in the application of tumor treatment (figure 1) [17]. One major application of MHNs is employed at the imaging diagnosis. In the process of tumor treatment, early detection of the tumor and a precise evaluation of therapy effect is crucial. To fulfill the requirement of precise disease evaluation, many imaging diagnosis techniques have been established over the past decades. However, all of these techniques have their own merits and drawbacks, and evaluation with more than one technique is usually needed. Traditionally, it is not possible to simultaneously analyze the disease with different techniques due to the contrast agents variation among these techniques. Luckily, the emergence of MHNs, as a multimodal imaging agent, could address this\nissue by combining different contrast agents into one entity. Another important application of MHNs is in the therapy, used as a mediator, e.g. in the hyperthermia therapy. When MHNs are used as an agent in the hyperthermia therapy, the energy-converting efficiency could be improved by manipulating the magnetic properties of MHNs. Also, it is possible to combine different therapies to develop one multifunctional therapy by introducing diverse functional agents into one entity, thereby opening a path to much more tumor treatment possibilities.\nIn this review, we summarized the latest literature on the biofunctional applications of MHNs, such as multimodal diagnosis and synergistic treatment. Owing to the distinctive structures and effective synthesis methods of MHNs, tremendous advances have been achieved in multimodal imaging techniques. In addition, we also discussed the potential of MHNs as a research platform where multiple components are integrated, allowing the realization of multifunctionality and greater medical effectiveness. Lastly, we discussed the latest progress of magnetic nanoparticles for theranostic treatment and concluded with an outlook on future prospects in this field.\n2. Synthesis and modification of biofunctional magnetic nanomaterials"
    }, {
      "heading" : "2.1. Synthesis of magnetic nanomaterials",
      "text" : "Specially designed MHNs, particularly iron oxide-based magnetic nanomaterials are intended for medical imaging with greater imaging sensitivity and resolution in the process of diagnosis and treatment [18–23]. The iron oxide-based magnetic nanomaterials are usually used as a functionally-\nFigure 1. The illustration of the multifunction of MHNs for diagnosis, therapy and theranostic treatment.\n2\nNanotechnology 30 (2019) 032002 Topical Review\nintegrated and size-tunable nanoplatform for multimodal imaging. Such functional units like radioisotopes and fluorescent molecules can be attached directly to surface of nanomaterials to achieve multiple functions and obtain highly accurate images. MHNs are typically synthesized by facile methods from (1) magnetic metals and their oxides, (2) the transition-metal-doped oxides and their metal alloys."
    }, {
      "heading" : "2.2. Hybridization of magnetic nanoparticles with different morphologies",
      "text" : "Unusually, the heterodimer MHNs have a special structure with two different functional parts and have more advantages than one single component, thus possess unique properties which benefit multimodal imaging and synergistic treatment. The heterodimer MHNs are usually fabricated through seedmediated growth. Sun’s group has lead in the fabrication of dumbbell-shaped Fe3O4–Au nanoparticles [24]. Pan et al synthesized the heterodimer Fe3O4–Au MHNs with average diameters of 11–14 nm and heterodimer Fe3O4-Ag\n125I through sequence growth [25, 26]. Xu’s group used a liquid– liquid interface colloidal method to control the sizes of both nanoparticles and functional units to construct the heterodimers [27]. With competitive advantages such as cost-efficiency and hypotoxicity, MHNs are considered to play an important role in dual modality imaging.\nCore–shell MHNs commonly contain different metal materials, such as platinum and bismuth, but their potential toxicity limits their medical applications. The iron oxide shell of core–shell MHNs, to reduce the release of toxic substances, is generally formed through the layer-by-layer method to get better biocompatibility. Wang’s group synthesized the PEGylated Fe@Fe3O4 core–shell MHNs with no obvious aggregation through separation by outer magnets [28]. FePt@Fe2O3 MHNs can also be obtained with the similar strategy. FePt has such a strong magnetism that the FePt@Fe2O3–PEG MHNs perform the potential application in T2 weighted MRI [29]. Pan et al encapsulated platinum nanorods by decomposing Fe(CO)5 to synthesize the Pt@Fe2O3 core–shell MHNs [30]. After further modification by 3,4-dihydroxyhydrocinnamic acid, the hybrid nanorods became hydrophilic and exhibited more energy conversion efficiency under a relatively low dose than the conventional spherical structure. In these study, polyethylene glycol (PEG) was used to improve the safety of materials. However, the use of PEG can also lead to toxicity [31, 32]. Therefore, PEGylation need to be used with caution."
    }, {
      "heading" : "3. Magnetic resonance imaging-based multimodal diagnosis",
      "text" : "With the continuous development of cancer research, people gradually realized that tumor therapy not only requires effective treatment methods, but also needs early diagnosis and accurate imaging of tumors. At present, commonly used imaging techniques in clinical practice [33–35] include magnetic resonance imaging (MRI), computed tomography\n(CT), positron emission tomography (PET) [36], single-photon emission computed tomography (SPECT), ultrasound (US), and photoacoustic imaging (PA). For example, Xie et al prepared a type of lipid nanobubble for detection of T lymphocytes through US imaging with targeted nanobubbles, which is proven to be a non-invasive and acute rejection detection method [37]. Although proven to be successful in the application of tumor treatment, these technologies still bear some limitations which hinder their application in clinical practice. Each imaging technology has its own characteristics, e.g. optical imaging is sensitive and convenient to use but has poor tissue penetration; MRI has a good soft tissue resolution, but its sensitivity is low; PET and SPECT possess high sensitivity but low spatial resolution. So only using one imaging technique may be not accurate enough for the tumor diagnosis and treatment.\nIn recent years, multimodal imaging technology with utilization of magnetic nanoparticles has emerged to overcome the limitations of single mode imaging by incorporating their respective advantages (table 1). The multimodal imaging technology has attracted extensive interest from research community because of its advantages (e.g. more imaging parameters, improved resolution and better biosafety). Magnetic nanoparticles are widely used in MRI imaging as the contrast agents. MRI has been proven to be a highly versatile and representative non-invasive imaging technique in clinical disease diagnosis since 1970s. MRI scanning can generate various chemical and physical data with detailed spatial images. Next, we will summarize numerous MRIbased imaging-guided diagnosis techniques, including bimodal and trimodal diagnosis."
    }, {
      "heading" : "3.1. MRI-based bimodal diagnosis",
      "text" : "CT can get the high-resolution images of soft tissue without high power and probe high-density structures with x-rays. MRI–CT bimodal diagnosis, known as one of the most common combination in bimodal imaging, can help to acquire more comprehensive diagnostic information. Much research has been carried out in this field, more related information will be introduced later. Fe3O4 and Au nanoparticles are well known to be highly biocompatible materials for the human body in medical applications. Many research groups have optimized the materials on several aspects such as size, shape and composition, and have reach some achievements at animal level. In general, Fe3O4–Au heterodimer nanoparticles revealed a MRI–CT contrast enhancing effect in the studies of rabbit models for MRI–CT biomedical imaging. Pan et al studied two different structures of Fe3O4–Au nanoparticles, namely the dumbbell-like and the heterodimer Fe3O4–Au nanoparticles [26], which are viewed as a new type of nanometer materials for MRI–CT bimodal imaging. The common characteristic of these two structures is their ability to conjugate with various functional units to realize multifunctionality with good biocompatibility. Other than the MHNs mentioned above, Hu’s group focused on the strawberry-like Fe3O4-Au MHNs with enhanced magnetic properties at atmospheric temperature [38]. All of these works\n3\nNanotechnology 30 (2019) 032002 Topical Review\nTable 1. Comparison of common imaging technology performance and advantages and disadvantages.\nImaging modality Spatial resolution Depth Imaging time Advantages Disadvantages\nMRI 0.01–1 mm No limit min–h High spatial resolution; good soft tissue contrast; quantitative Expensive; long imaging time; low sensitivity CT 1 mm No limit min High spatial resolution; excellent anatomical images Radioactive; poor contrast of soft tissue PET 1–10 mm No limit min–h High sensitivity; quantitative; tracer; combined therapy Radioactive; low spatial resolution SPECT 1–15 mm No limit min–h High sensitivity; quantitative; tracer; combined therapy Radioactive; low spatial resolution; long imaging time US 0.05–1 mm cm s–min High sensitivity; good spatial resolution; portable; economical Depending on the operator’s technical level; lacking available probe PA 0.01–1 mm cm s–min Provide high contrast and resolution tissue imaging and combined\nwith the advantages of US Limited detecting depth; limited in bone and air organization\n4\nN anotechnology 30 (2019) 032002 TopicalR eview\nhave fully exploited the features of Fe3O4 and Au in the imaging diagnosis. Additionally, there are many other nanomaterials used in MRI–CT bimodal imaging. For example, Yu’s group used the FePt-based MHNs for T2-weighted MRI and CT [39]. The iron platinum-DMSA/PEGylated graphene oxide–folic acid (FePt-DMSA/GO-PEG-FA) equipped with the selective contrast enhancement is successfully applied in the MRI–CT bimodal imaging diagnosis."
    }, {
      "heading" : "3.2. MRI-based multimodal diagnosis",
      "text" : "Theoretically, any feasible imaging methods can be combined into a multimodal imaging method, leading to diverse multimodal imaging. Owing to its obvious advantages compared to single-mode imaging, multimodal imaging has an attractive application prospect and is developed rapidly in recent years for the tumor early diagnosis, disease recognition, treatment, curative effect monitoring, and clinical studies. Currently, the common MRI-based trimodal imaging diagnosis methods are MRI/PET/NIFR [4], MRI/PET/SPECT [33], and MRI/PA/ CT [40]. The main disadvantage of MRI is its low sensitivity and long duration. Optical imagings such as NIFR, PA and radionuclide imagines such as PET have higher resolution and detection sensitivity, which can make up for the defects of single imaging [41, 42]. Along with the trimodal imaging, researchers have also employed more advanced tetramodal imaging to improve the diagnostic efficiency. Notably, Liu’s group used the cation exchange method to synthesize a type of FeSe2-decorated Bi2Se3 nanosheets for a combined strategy including PTT-RT synergistic therapy and MRI/CT/PA/ PET tetramodal imaging (figure 2) [43]. The density of FeSe2 nanoparticles at the Bi2Se3 surface can be adjusted by changing the amount of Bi, and its compatibility can be improved by the PEGylation. The FeSe2-decorated Bi2Se3 nanosheets take the advantages of high r2 relaxation, strong absorbance of x-rays and NIR, and 64Cu chelate-free radiolabeling, enabling the MHNs applications in tetramodal MR/CT/PA/ PET imaging. Due to its intrinsic physical properties, the synergistic tumor destruction effect was achieved in PTT and\nRT. The observed non-toxicity provides the possibility for further development of their application in vivo.\nIn addition to the above-mentioned applications in tetramodal imaging, Fe3O4-Au dumbbell MHNs can also be used in MRI, PET and near infrared fluorescence trimodal imaging. Chen’s group prepared a PET–NIFR–MRI trimodal imaging probe by using the Fe3O4-based MHNs [44]. Kang’s group has made great efforts to fabricate a novel ‘All-in-One’ MHNs@PES-Cy7/2-DG for trimodal imaging-guided PTT– magnetic hyperthermia therapy (MHT) to achieve outstanding therapeutic performance [45]. The MHNs@PES-Cy7/2-DG can be used in combined PTT–MHT under the guidance of PA/NIFR/MRI trimodal imaging to completely eliminate the tumor cells with high precision. This research impacts the exploration of nanoplatforms for multibmodal diagnosis and treatment."
    }, {
      "heading" : "4. MHNs for cancer therapy",
      "text" : ""
    }, {
      "heading" : "4.1. MHT and PTT",
      "text" : "Hyperthermia therapy has been widely used in clinical cancer therapy for a long time [46]. The treatment process of MHT is based on the temperature rise of magnetic nanoparticles combining with chemotherapy or radiotherapy to kill cancerous cells. The MHNs under an external alternating magnetic field transform the magnetic energy into heat through the Néel and Brownian relaxation mechanisms to destroy the tumor via a non-invasive approach [47–49]. Due to their advantages of minimizing the damage to circumambient tissues, MHNs with promising patents have attracted an increasing attention nowadays. For example, Tay et al combined the MHT with a new imaging modality, magnetic particle imaging (MPI), to realize the image-guided treatment with considerable precision [50]. They synthesized unique iron oxide MHNs as the powerful nanoplatform for quantitative MPI-guided MHT with higher precision and zero ionizing radiation.\nPTT is a promising non-invasive cancer therapy which converts laser energy into heat to effectively kill tumor cells which are difficult to be eliminated with surgery. The main reason to use PTT is attributed to that tumor cells are more temperature-sensitive than healthy human tissues [51–53]. MHNs-based PTT is considered to be safe, controllable, biodegradable and non-toxic. Many researchers are making great efforts to the prepare various MHNs used in PTT. Yang’s group fabricated a multifunctional PEGylated Fe@Fe3O4 MHNs to meet the basic preconditions of PTT [54]. The PEGylated @Fe3O4 MHNs integrate imaging and treatments in photothermal conversion, allowing for higher efficiency, better stability and lower toxicity in clinical application. To monitor the process and performance of treatment, Li et al synthesized an effective magnetic theranostic nanoplatform (iron oxide-based nanoparticles IONC@Au-PEG) [55]. This type of MHNs has the superiorities such as effective clearance of the cancer cells under lower power density and dual-modal (MRI-PA) time-dependent\nFigure 2. The illustration of the structure of FeSe2-decorated Bi2Se3 nanosheets for MRI/CT/PA/PET tetramodal imaging diagnosis and theranostic treatment. [43] John Wiley & Sons. © 2016 WILEY‐ VCH Verlag GmbH & Co. KGaA, Weinheim..\n5\nNanotechnology 30 (2019) 032002 Topical Review\nimaging throughout the treatment. Some other studies on this MHNs are also reported. For example, Fu et al synthesized the GO–IONP–PEG NPs with the guidance of diffusion weighted MRI to enhance the PTT effects [56]. Lin et al prepared a novel Fe3O4@polydopamine core–shell NCs (Fe3O4@PDA NCs) for both PTT and the detection of mRNA [57]. Wu et al prepared a rattle-type Fe3O4@CuS NPs for imaged-guided PTT at both the first (808 nm) and second (1064 nm) NIR windows [58].\nIn practice, MHT and PTT are often used in combination to enhance the therapeutic effect. Chen’s group reported a synergistic combination of MHT and PTT under the guidance of MRI with core–shell MnFe2O4/PB MHNs [59]. By introducing the surface porous shell, the water exchange is improved efficiently to intensify the MRI and the traverse of NIR-light through the shell, consequently the thermal effect can be enhanced. So the multifunctional MnFe2O4/PB MHNs can be used as theranostic agents in future clinical diagnosis and treatment."
    }, {
      "heading" : "4.2. Cancer RT",
      "text" : "RT is a local treatment method that utilizes radiation to treat tumors. It is one of the most effective treatments which are commonly used for malignant tumors in clinical practice [40]. However, RT still has the drawbacks of high radiation dose, large side effects on healthy tissues, and particularly strong radiation resistance of tumor cells [60]. With the development of nanomedicine, multifunctional nano-radiotherapy sensitizers have provided new opportunities for intensifying the radiosensitivity of tumor cells and improving the efficacy of radiotherapy.\nMultifunctional nanomaterials with high atomic number (high-Z) elements can either promote cell damage through photoelectric interaction, or be loaded with various drugs\nsuch as chemotherapy and genes. Therefore, multifunctional nanomaterials are able to selectively kill cytotoxic cells, regulate cell pathways, and increase cell radiation sensitivity [41, 42, 61]. Meanwhile, it can realize the synergistic treatment of chemotherapy, hyperthermia, photodynamic therapy, gene therapy and radiotherapy, subsequently overcoming deficiencies of single radiotherapy and complementing advantages from each therapy. Pan et al fabricated multifunctional PEGylated Fe@Bi2S3 nanoparticles for bimodal imaging-guided synergistic thermoradiotherapy (figure 3) [62]. The magnetic Fe core is a medium for MRI while the Bi2S3 shell is a radiosensitizer for CT due to its high-Z and strong absorbance in the NIR region. Therefore, the PEGylated Fe@Bi2S3 nanoparticles exhibit no obvious toxicity at the therapeutic dose and perform the remarkable ability for simultaneous diagnosis and synergistic thermoradiotherapy."
    }, {
      "heading" : "5. MHNs for theranostic treatment",
      "text" : "Multimodality imaging improves diagnostic accuracy and collaborative therapy is in favor to therapeutic efficacy. However, the separation of diagnosis and treatment severely compromises the timely detection and treatment of cancer. But the advantages of magnetic nanomaterials has made it possible to implement theranostic therapies. Multifunctional MHNs with comprehensive diagnostic and therapeutic purposes are widely used in the theranostic treatments [63].\nThe Fe3O4@MSNs with high biocompatibility, good enzyme responsiveness and selectivity can realize the controlled drug release, chemotherapy and MRI-guided diagnosis [5]. The Fe3O4@MSNs work as the stimulus-responsive multifunctional nanomaterials for accurate diagnosis and efficient treatment to inhibit tumor growth (figure 4).\n6\nYang et al used Au@FeS core–shell MHNs as a powerful theranostic nanoplatforms benefitting from the synergistic effect of thermoradiotherapy and the guidance of the T2-weighted MRI [63]. Pan et al synthesized the PEGylated Au@Pt nanodendrites to enhance the absorption of the first NIR windows (808 nm wavelength) [64]. Such nanodendrites occupy excellent therapeutic effect for combined PTT and RT, thus significantly enhanced effect for CT imaging in the promising clinical application. Moreover, Liu’s group used manganese dioxide coated WS2@Fe3O4/sSiO2 in response to pH-responsive MRI to integrate PTT and RT in the cancer synergistic treatment [65]. The WS2 has a strong absorbance of NIR and x-rays, and the MnO2 can decompose the H2O2 (generated by the tumor) to reduce the tumor hypoxia, so that the RT resistance caused by hypoxia can be overcome. The albumin assisted ultrasmall FeS2 nanoparticles coupling with Chlorin e6 (Ce6), as a photosensitive molecule, were synthesized for optical/PA/MRI trimodal imaging-guided photothermal enhanced photodynamic therapy (figure 5) [66]. Taking advantage of many superior properties, FeS2@BSA-Ce6 can be successfully applied in cancer synergistic treatment with no apparent toxicity. Meanwhile, the carefully-prepared of hollow porous iron oxide nanoparticles (PIONs) as theranostic nanoagents for T2-weighted MRI and photothermal/chemotherapy has been reported by Pan et al [67]. The PIONs with the porous structure can load doxorubicin hydrochloride to improve chemotherapeutic efficacy. Furthermore, the PIONs have stable photothermal effect and lessen the dosage of the chemotherapeutic agents to alleviate the side effect.\n7"
    }, {
      "heading" : "6. Conclusion",
      "text" : "MHNs possess a broad spectrum of unique features that make them significantly useful for biomedical technologies, such as in the field of multimodal imaging diagnosis and theranostic treatment. This review briefly concludes the synthesis methods and main types of MHNs (e.g. the heterodimer MHNs and core–shell MHNs). Successful applications of MHNs are also presented. Image-guided MHNs can effectively monitor the treatment response to the disease and nanoparticles activity on the disease sites. The MHNs can enhance the synergistic medical effectiveness when combined with other therapies and have great potential to realize therapeutic multifunctionality. Despite the substantial achievements that have been made for the MHNs as theranostic nanomaterials, there are still considerable challenges in optimizing the compositions of MHNs. In many studies, MHNs reach the tumor tissues by an enhanced permeation and retention effect which is passively targeted and inefficient. It is better to develop MHNs conjugated with targeting molecules to improve the target efficiency of MHNs at tumor tissues. Nevertheless, we hope that the MHNs of multimodal imaging and disease diagnosis will provide a great help for cancer treatment in the near future. Therefore, the future research of MHNs is suggested to focus on these above-mentioned aspects, to help MHNs contribute more to cancer diagnosis and therapy."
    }, {
      "heading" : "Acknowledgments",
      "text" : "The authors acknowledge financial support from the National Natural Science Foundation of China (51402203), the Science and Technology Program of Suzhou (SYG201736), Jiangsu Provincial Key Laboratory of Radiation Medicine and Protection and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The Project is also sponsored by Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices, Soochow University.\nORCID iDs\nYue Pan https://orcid.org/0000-0001-7709-0508"
    } ],
    "references" : [ {
      "title" : "Metal-based hybrid nanoparticles as radiosensitizers in cancer therapy",
      "author" : [ "Y Pan", "P Xue", "S Liu", "L Zhang", "Q Guan", "J Zhu", "X Tian" ],
      "venue" : "Colloid Interface Sci. Commun",
      "citeRegEx" : "2",
      "shortCiteRegEx" : "2",
      "year" : 2018
    }, {
      "title" : "Toward the next-generation nanomedicines: design of multifunctional multiblock polyurethanes for effective cancer treatment",
      "author" : [ "M Ding", "N Song", "X He", "J Li", "L Zhou", "H Tan", "Q Fu", "Q Gu" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "3",
      "shortCiteRegEx" : "3",
      "year" : 2013
    }, {
      "title" : "New forms of superparamagnetic nanoparticles for biomedical applications Adv",
      "author" : [ "C Xu", "S Song" ],
      "venue" : "Drug Deliv. Rev",
      "citeRegEx" : "4",
      "shortCiteRegEx" : "4",
      "year" : 2013
    }, {
      "title" : "Multifunctional magnetic mesoporous silica nanoagents for in vivo enzyme-responsive drug delivery and MR imaging Nanotheranostics 2 233–42",
      "author" : [ "E Li", "Y Yang", "G Hao", "X Yi", "S Zhang", "Y Pan", "B Xing", "M Gao" ],
      "venue" : null,
      "citeRegEx" : "5",
      "shortCiteRegEx" : "5",
      "year" : 2018
    }, {
      "title" : "Fabrication of multifoliate PtRu bimetallic nanocomplexes for computed tomography imaging and enhanced synergistic thermoradiotherapy",
      "author" : [ "Y Deng" ],
      "venue" : "ACS Appl. Mater. Interfaces",
      "citeRegEx" : "6",
      "shortCiteRegEx" : "6",
      "year" : 2018
    }, {
      "title" : "Organic phase syntheses of magnetic nanoparticles and their applications",
      "author" : [ "L Wu", "A Mendoza-Garcia", "Q Li", "S Sun" ],
      "venue" : "Chem. Rev",
      "citeRegEx" : "7",
      "shortCiteRegEx" : "7",
      "year" : 2016
    }, {
      "title" : "Construction of iron oxide nanoparticle-based hybrid platforms for tumor imaging and therapy",
      "author" : [ "Y Hu", "S Mignani", "P Majoral J", "M Shen", "X Shi" ],
      "venue" : "Chem. Soc. Rev",
      "citeRegEx" : "8",
      "shortCiteRegEx" : "8",
      "year" : 2018
    }, {
      "title" : "New advances on the marrying of UCNPs and photothermal agents for imaging-guided diagnosis and the therapy of tumors",
      "author" : [ "D Wang", "B Liu", "Z Quan", "C Li", "Z Hou", "B Xing", "J Lin" ],
      "venue" : "J. Mater. Chem. B",
      "citeRegEx" : "9",
      "shortCiteRegEx" : "9",
      "year" : 2017
    }, {
      "title" : "Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications Biomater",
      "author" : [ "K Gupta A", "M Gupta" ],
      "venue" : null,
      "citeRegEx" : "10",
      "shortCiteRegEx" : "10",
      "year" : 2005
    }, {
      "title" : "Multifunctional fluorescent magnetic nanoparticles: synthesis, characterization and targeted cell imaging applications Chin",
      "author" : [ "L Zhou", "X Zhang", "L Liu", "Y Wei", "J Yuan" ],
      "venue" : "J. Chem",
      "citeRegEx" : "11",
      "shortCiteRegEx" : "11",
      "year" : 2017
    }, {
      "title" : "A supramolecular approach for versatile biofunctionalization of magnetic nanoparticles",
      "author" : [ "C Hu", "T Wei", "W Zhan", "Y Qu", "Y Pan", "Q Yu", "H Chen" ],
      "venue" : "J. Mater. Chem. B",
      "citeRegEx" : "12",
      "shortCiteRegEx" : "12",
      "year" : 2018
    }, {
      "title" : "CMCTS stabilized Fe3O4 particles with extremely low toxicity as highly efficient near-infrared photothermal agents for in vivo tumor ablation",
      "author" : [ "S Shen", "F Kong", "X Guo", "L Wu", "H Shen", "M Xie", "X Wang", "Y Jin", "Y Ge" ],
      "venue" : "Nanoscale",
      "citeRegEx" : "13",
      "shortCiteRegEx" : "13",
      "year" : 2013
    }, {
      "title" : "Highly crystallized iron oxide nanoparticles as effective and biodegradable mediators for photothermal cancer therapy",
      "author" : [ "H Chen", "J Burnett", "F Zhang", "J Zhang", "H Paholak", "D Sun" ],
      "venue" : "J. Mater. Chem. B",
      "citeRegEx" : "14",
      "shortCiteRegEx" : "14",
      "year" : 2014
    }, {
      "title" : "A facile strategy for electrochemical analysis of hydrogen peroxide based on multifunctional Fe3O4@Ag nanocomposites",
      "author" : [ "Z Guo", "J Xu", "J Zhang", "Y Hu", "Y Pan", "P Miao" ],
      "venue" : "ACS Appl. Bio Mater",
      "citeRegEx" : "15",
      "shortCiteRegEx" : "15",
      "year" : 2018
    }, {
      "title" : "Clickable and imageable multiblock polymer micelles with magnetically guided and PEG-switched targeting and release property for precise tumor theranosis Biomaterials",
      "author" : [ "J Wei", "X Shuai", "R Wang", "X He", "Y Li", "M Ding", "J Li", "H Tan", "Q Fu" ],
      "venue" : null,
      "citeRegEx" : "16",
      "shortCiteRegEx" : "16",
      "year" : 2017
    }, {
      "title" : "Functional magnetic hybrid nanomaterials for biomedical diagnosis and treatment",
      "author" : [ "X Tian", "L Zhang", "M Yang", "L Bai", "Y Dai", "Z Yu", "Y Pan" ],
      "venue" : "Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol",
      "citeRegEx" : "17",
      "shortCiteRegEx" : "17",
      "year" : 2018
    }, {
      "title" : "Dual-functional Au-Fe3O4 dumbbell nanoparticles for sensitive and selective turn-on fluorescent detection of cyanide based on the inner filter effect",
      "author" : [ "Y Zhai", "L Jin", "P Wang", "S Dong" ],
      "venue" : "Chem. Commun",
      "citeRegEx" : "18",
      "shortCiteRegEx" : "18",
      "year" : 2011
    }, {
      "title" : "Colloidosome-based synthesis of a multifunctional nanostructure of silver and hollow iron oxide nanoparticles",
      "author" : [ "Y Pan", "J Gao", "B Zhang", "X Zhang", "B Xu" ],
      "venue" : "Langmuir",
      "citeRegEx" : "19",
      "shortCiteRegEx" : "19",
      "year" : 2010
    }, {
      "title" : "DNA modified Fe3O4@Au magnetic nanoparticles as selective probes for simultaneous detection of heavy metal ions",
      "author" : [ "P Miao", "Y Tang", "L Wang" ],
      "venue" : "ACS Appl. Mater. Interfaces",
      "citeRegEx" : "20",
      "shortCiteRegEx" : "20",
      "year" : 2017
    }, {
      "title" : "Chemical synthesis and assembly of uniformly sized iron oxide nanoparticles for medical applications",
      "author" : [ "D Ling", "N Lee", "T Hyeon" ],
      "venue" : "Acc. Chem. Res",
      "citeRegEx" : "21",
      "shortCiteRegEx" : "21",
      "year" : 2015
    }, {
      "title" : "Monodisperse magnetic nanoparticles for theranostic applications Acc",
      "author" : [ "D Ho", "X Sun", "S Sun" ],
      "venue" : "Chem. Res",
      "citeRegEx" : "22",
      "shortCiteRegEx" : "22",
      "year" : 2011
    }, {
      "title" : "Multifunctional magnetic nanoparticles: design, synthesis, and biomedical applications Acc",
      "author" : [ "J Gao", "H Gu", "B Xu" ],
      "venue" : "Chem. Res",
      "citeRegEx" : "23",
      "shortCiteRegEx" : "23",
      "year" : 2009
    }, {
      "title" : "Au-Fe3O4 dumbbell nanoparticles as dual-functional probes",
      "author" : [ "C Xu", "J Xie", "D Ho", "C Wang", "N Kohler", "G Walsh E", "R Morgan J", "E Chin Y", "S Sun" ],
      "venue" : "Angew. Chem.,",
      "citeRegEx" : "24",
      "shortCiteRegEx" : "24",
      "year" : 2008
    }, {
      "title" : "Synthesis of heterodimer radionuclide nanoparticles for magnetic resonance and single-photon emission computed tomography dual-modality imaging Nanoscale",
      "author" : [ "J Zhu" ],
      "venue" : null,
      "citeRegEx" : "25",
      "shortCiteRegEx" : "25",
      "year" : 2015
    }, {
      "title" : "Synthesis of Au-Fe3O4 heterostructured nanoparticles for in vivo computed tomography and magnetic resonance dual model imaging Nanoscale",
      "author" : [ "J Zhu", "Y Lu", "Y Li", "J Jiang", "L Cheng", "Z Liu", "L Guo", "Y Pan", "H Gu" ],
      "venue" : null,
      "citeRegEx" : "26",
      "shortCiteRegEx" : "26",
      "year" : 2014
    }, {
      "title" : "Heterodimers of nanoparticles: formation at a liquid–liquid interface and particle-specific surface modification",
      "author" : [ "Z Gu H Y", "J Gao", "K Chang C", "B Xu" ],
      "venue" : "J. Am. Chem. Soc",
      "citeRegEx" : "27",
      "shortCiteRegEx" : "27",
      "year" : 2005
    }, {
      "title" : "Iron/iron oxide core/shell nanoparticles for magnetic targeting MRI and near-infrared photothermal therapy",
      "author" : [ "Z Zhou", "Y Sun", "J Shen", "J Wei", "C Yu", "B Kong", "W Liu", "H Yang", "S Yang", "W Wang" ],
      "venue" : "Biomaterials",
      "citeRegEx" : "28",
      "shortCiteRegEx" : "28",
      "year" : 2014
    }, {
      "title" : "PEGylated FePt@Fe2O3 core–shell magnetic nanoparticles: potential theranostic applications and in vivo toxicity",
      "author" : [ "Y Liu", "K Yang", "L Cheng", "J Zhu", "X Ma", "H Xu", "Y Li", "L Guo", "H Gu", "Z Liu" ],
      "venue" : "Nanomedicine",
      "citeRegEx" : "29",
      "shortCiteRegEx" : "29",
      "year" : 2013
    }, {
      "title" : "Facile preparation of hybrid core–shell nanorods for photothermal and radiation combined therapy",
      "author" : [ "Y Deng", "E Li", "X Cheng", "J Zhu", "S Lu", "C Ge", "H Gu", "Y Pan" ],
      "venue" : "Nanoscale",
      "citeRegEx" : "30",
      "shortCiteRegEx" : "30",
      "year" : 2016
    }, {
      "title" : "Role of polyethylene glycol integrity in specific receptor targeting of carbon nanotubes to cancer cells",
      "author" : [ "R Zeineldin", "M Alhaik", "G Hudson L" ],
      "venue" : "Nano Lett",
      "citeRegEx" : "31",
      "shortCiteRegEx" : "31",
      "year" : 2009
    }, {
      "title" : "Rapid detection of polyethylene glycol sonolysis upon functionalization of carbon nanomaterials",
      "author" : [ "S Murali V", "R Wang", "A Mikoryak C", "P Pantano", "R Draper" ],
      "venue" : "Exp. Biol. Med",
      "citeRegEx" : "32",
      "shortCiteRegEx" : "32",
      "year" : 2015
    }, {
      "title" : "Recent advances in magnetic nanoparticle-based multi-modal imaging",
      "author" : [ "T-H Shin", "Y Choi", "S Kim", "J Cheon" ],
      "venue" : "Chem. Soc. Rev",
      "citeRegEx" : "33",
      "shortCiteRegEx" : "33",
      "year" : 2015
    }, {
      "title" : "Molecular imaging with theranostic nanoparticles",
      "author" : [ "V Jokerst J", "S Gambhir S" ],
      "venue" : "Acc. Chem. Res",
      "citeRegEx" : "35",
      "shortCiteRegEx" : "35",
      "year" : 2011
    }, {
      "title" : "Chelator-free synthesis of a dual-modality PET/MRI agent Angew",
      "author" : [ "F Chen", "A Ellison P", "M Lewis C", "H Hong", "Y Zhang", "S Shi", "R Hernandez", "E Meyerand M", "E Barnhart T", "W Cai" ],
      "venue" : null,
      "citeRegEx" : "36",
      "shortCiteRegEx" : "36",
      "year" : 2013
    }, {
      "title" : "Ultrasound molecular imaging of acute cardiac transplantation rejection using nanobubbles targeted to T lymphocytes",
      "author" : [ "J Liu" ],
      "venue" : "Biomaterials",
      "citeRegEx" : "37",
      "shortCiteRegEx" : "37",
      "year" : 2018
    }, {
      "title" : "Synthesis and application of strawberry-like Fe3O4-Au nanoparticles as CT-MR dualmodality contrast agents in accurate detection of the progressive liver disease",
      "author" : [ "Y Zhao H", "S Liu", "J He", "C Pan C", "H Li", "Y Zhou Z", "Y Ding", "D Huo", "Y Hu" ],
      "venue" : "Biomaterials",
      "citeRegEx" : "38",
      "shortCiteRegEx" : "38",
      "year" : 2015
    }, {
      "title" : "pH-Responsive, self-sacrificial nanotheranostic agent for potential in vivo and in vitro dual modal MRI/CT imaging, real-time, and in situ monitoring of cancer therapy",
      "author" : [ "L Yue", "J Wang", "Z Dai", "Z Hu", "X Chen", "Y Qi", "X Zheng", "D Yu" ],
      "venue" : "Bioconjug. Chem",
      "citeRegEx" : "39",
      "shortCiteRegEx" : "39",
      "year" : 2017
    }, {
      "title" : "Emerging nanotechnology and advanced materials for cancer radiation therapy",
      "author" : [ "G Song", "L Cheng", "Y Chao", "K Yang", "Z Liu" ],
      "venue" : "Adv. Mater",
      "citeRegEx" : "40",
      "shortCiteRegEx" : "40",
      "year" : 2017
    }, {
      "title" : "Application of multifunctional nanomaterials in tumor radiosensitization",
      "author" : [ "L Gong", "J Xie", "S Zhu", "Z Gu", "Y Zhao" ],
      "venue" : "Acta Phys.-Chim. Sin",
      "citeRegEx" : "41",
      "shortCiteRegEx" : "41",
      "year" : 2018
    }, {
      "title" : "FeSe2-decorated Bi2Se3 nanosheets fabricated via cation exchange for chelator-free 64Cu-labeling and multimodal image-guided photothermalradiation therapy",
      "author" : [ "L Cheng" ],
      "venue" : "Adv. Funct. Mater",
      "citeRegEx" : "43",
      "shortCiteRegEx" : "43",
      "year" : 2016
    }, {
      "title" : "PET/NIRF/MRI triple functional iron oxide nanoparticles Biomaterials",
      "author" : [ "J Xie", "K Chen", "J Huang", "S Lee", "J Wang", "J Gao", "X Li", "X Chen" ],
      "venue" : null,
      "citeRegEx" : "44",
      "shortCiteRegEx" : "44",
      "year" : 2010
    }, {
      "title" : "All-in-One’ nanoparticles for trimodality imaging-guided intracellular photo-magnetic hyperthermia therapy under intravenous administration",
      "author" : [ "H Yan" ],
      "venue" : "Adv. Funct. Mater",
      "citeRegEx" : "45",
      "shortCiteRegEx" : "45",
      "year" : 2018
    }, {
      "title" : "Tailoring La1−xSrxMnO3 (0.25x0.35) nanoparticles for selfregulating magnetic hyperthermia therapy: an in vivo study",
      "author" : [ "M Soleymani", "M Edrissi", "M Alizadeh A" ],
      "venue" : "J. Mater. Chem. B",
      "citeRegEx" : "46",
      "shortCiteRegEx" : "46",
      "year" : 2017
    }, {
      "title" : "Nanoscale magnetism control via surface and exchange anisotropy for optimized ferrimagnetic hysteresis",
      "author" : [ "H Noh S", "W Na", "T Jang J", "H Lee J", "J Lee E", "H Moon S", "Y Lim", "S Shin J", "J Cheon" ],
      "venue" : "Nano Lett",
      "citeRegEx" : "47",
      "shortCiteRegEx" : "47",
      "year" : 2012
    }, {
      "title" : "Magnetic hyperthermia efficiency in the cellular environment for different nanoparticle designs Biomater",
      "author" : [ "R Di Corato", "A Espinosa", "L Lartigue", "M Tharaud", "S Chat", "T Pellegrino", "C Menager", "F Gazeau", "C Wilhelm" ],
      "venue" : null,
      "citeRegEx" : "48",
      "shortCiteRegEx" : "48",
      "year" : 2014
    }, {
      "title" : "Cooperative organization in iron oxide multi-core nanoparticles potentiates their efficiency as heating mediators and MRI contrast agents",
      "author" : [ "H Le ́naic Lartigue P", "D Alloyeau", "P Clarke S", "Michael Lévy", "J-C Bacri", "B Rana Bazzi D F", "C Wilhelm", "F Gazeau" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "49",
      "shortCiteRegEx" : "49",
      "year" : 2012
    }, {
      "title" : "Magnetic particle imaging-guided heating in vivo using gradient fields for arbitrary localization of magnetic hyperthermia therapy",
      "author" : [ "W Tay Z" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "50",
      "shortCiteRegEx" : "50",
      "year" : 2018
    }, {
      "title" : "Therapeutic applications of iron oxide based nanoparticles in cancer: basic concepts and recent advances Biomater",
      "author" : [ "M Saeed", "W Ren", "A Wu" ],
      "venue" : null,
      "citeRegEx" : "51",
      "shortCiteRegEx" : "51",
      "year" : 2018
    }, {
      "title" : "Magnetic nanoparticle clusters for photothermal therapy with near-infrared irradiation Biomater",
      "author" : [ "S Shen", "S Wang", "R Zheng", "X Zhu", "X Jiang", "D Fu", "W Yang" ],
      "venue" : null,
      "citeRegEx" : "52",
      "shortCiteRegEx" : "52",
      "year" : 2015
    }, {
      "title" : "Using porous magnetic iron oxide nanomaterials as a facile photoporation nanoplatform for macromolecular delivery",
      "author" : [ "L Wang", "J Wu", "Y Hu", "C Hu", "Y Pan", "Q Yu", "H Chen" ],
      "venue" : "J. Mater. Chem. B",
      "citeRegEx" : "53",
      "shortCiteRegEx" : "53",
      "year" : 2018
    }, {
      "title" : "Photoacoustic-enabled self-guidance in magnetic-hyperthermia Fe@Fe3O4 nanoparticles for theranostics in vivo",
      "author" : [ "P Zhou", "H Zhao", "Q Wang", "Z Zhou", "J Wang", "G Deng", "X Wang", "Q Liu", "H Yang", "S Yang" ],
      "venue" : "Adv. Healthc. Mater",
      "citeRegEx" : "54",
      "shortCiteRegEx" : "54",
      "year" : 2018
    }, {
      "title" : "Magnetic targeting enhanced theranostic strategy based on multimodal imaging for selective ablation of cancer",
      "author" : [ "Z Li", "S Yin", "L Cheng", "K Yang", "Y Li", "Z Liu" ],
      "venue" : "Adv. Funct. Mater",
      "citeRegEx" : "55",
      "shortCiteRegEx" : "55",
      "year" : 2014
    }, {
      "title" : "Diffusion-weighted magnetic resonance imaging for therapy response monitoring and early treatment prediction of photothermal therapy",
      "author" : [ "G Fu", "L Zhu", "K Yang", "R Zhuang", "J Xie", "F Zhang" ],
      "venue" : "ACS Appl. Mater. Interfaces",
      "citeRegEx" : "56",
      "shortCiteRegEx" : "56",
      "year" : 2016
    }, {
      "title" : "Rattle-type Fe3O4@CuS developed to conduct magnetically guided photoinduced hyperthermia at first and second NIR biological windows",
      "author" : [ "Wu Z-C", "Li W-P", "Luo C-H", "Su C-H", "Yeh C-S" ],
      "venue" : "Adv. Funct. Mater",
      "citeRegEx" : "58",
      "shortCiteRegEx" : "58",
      "year" : 2015
    }, {
      "title" : "Porous MnFe2O4-decorated PB nanocomposites: a new theranostic agent for boosted  T1/T2 MRI-guided synergistic photothermal/magnetic hyperthermia",
      "author" : [ "X Zhou", "X Lv", "W Zhao", "T Zhou", "S Zhang", "Z Shi", "S Ye", "L Ren", "Z Chen" ],
      "venue" : "RSC Adv",
      "citeRegEx" : "59",
      "shortCiteRegEx" : "59",
      "year" : 2018
    }, {
      "title" : "Microenvironment and radiation therapy",
      "author" : [ "M Yoshimura", "S Itasaka", "H Harada", "M Hiraoka" ],
      "venue" : "Biomed. Res. Int",
      "citeRegEx" : "60",
      "shortCiteRegEx" : "60",
      "year" : 2013
    }, {
      "title" : "Functional nanomaterials for phototherapies of cancer",
      "author" : [ "L Cheng", "C Wang", "L Feng", "K Yang", "Z Liu" ],
      "venue" : "Chem. Rev",
      "citeRegEx" : "61",
      "shortCiteRegEx" : "61",
      "year" : 2014
    }, {
      "title" : "Fabrication of PEGylated Fe@Bi2S3 nanocomposites for dualmode imaging and synergistic thermoradiotherapy Biomater",
      "author" : [ "C Er L X", "Y Deng", "J Zhua", "X Xu", "E Saw P", "H Gu", "C Ge", "Y Pan" ],
      "venue" : null,
      "citeRegEx" : "62",
      "shortCiteRegEx" : "62",
      "year" : 2018
    }, {
      "title" : "Synergistic effect of thermo-radiotherapy using Au@FeS core–shell nanoparticles as multifunctional therapeutic nanoagents Part",
      "author" : [ "J Chen", "M Li", "X Yi", "Q Zhao", "L Chen", "C Yang", "J Wu", "K Yang" ],
      "venue" : "Part. Syst. Char",
      "citeRegEx" : "63",
      "shortCiteRegEx" : "63",
      "year" : 2017
    }, {
      "title" : "PEGylated Au@Pt nanodendrites as novel theranostic agents for computed tomography imaging and photothermal/radiation synergistic therapy",
      "author" : [ "X Liu", "X Zhang", "M Zhu", "G Lin", "J Liu", "Z Zhou", "X Tian", "Y Pan" ],
      "venue" : "ACS Appl. Mater. Interfaces",
      "citeRegEx" : "64",
      "shortCiteRegEx" : "64",
      "year" : 2017
    }, {
      "title" : "Manganese dioxide coated WS2@Fe3O4/sSiO2 nanocomposites for pH-responsive MR imaging and oxygen-elevated synergetic therapy",
      "author" : [ "G Yang", "R Zhang", "C Liang", "H Zhao", "X Yi", "S Shen", "K Yang", "L Cheng", "Z Liu" ],
      "venue" : "Small",
      "citeRegEx" : "65",
      "shortCiteRegEx" : "65",
      "year" : 2018
    }, {
      "title" : "Albumin-assisted synthesis of ultrasmall FeS2 nanodots for imaging-guided photothermal enhanced photodynamic therapy",
      "author" : [ "Q Jin", "J Liu", "W Zhu", "Z Dong", "Z Liu", "L Cheng" ],
      "venue" : "ACS Appl. Mater. Interfaces",
      "citeRegEx" : "66",
      "shortCiteRegEx" : "66",
      "year" : 2018
    }, {
      "title" : "Multifunctional porous iron oxide nanoagents for MRI and photothermal/chemo synergistic therapy",
      "author" : [ "Y Hu", "H Hu", "J Yan", "C Zhang", "Y Li", "M Wang", "W Tan", "J Liu", "Y Pan" ],
      "venue" : "Bioconjug. Chem",
      "citeRegEx" : "67",
      "shortCiteRegEx" : "67",
      "year" : 2018
    } ],
    "referenceMentions" : [ {
      "referenceID" : 0,
      "context" : "Cancer is one of the biggest threats to human life and health [1, 2].",
      "startOffset" : 62,
      "endOffset" : 68
    }, {
      "referenceID" : 1,
      "context" : "have endeavored to develop diagnostic and therapeutic technologies over the past decades [3, 4].",
      "startOffset" : 89,
      "endOffset" : 95
    }, {
      "referenceID" : 2,
      "context" : "have endeavored to develop diagnostic and therapeutic technologies over the past decades [3, 4].",
      "startOffset" : 89,
      "endOffset" : 95
    }, {
      "referenceID" : 3,
      "context" : "Traditional treatments, including surgery, photothermal therapy (PTT), chemotherapy and radiation therapy (RT), have many drawbacks [5].",
      "startOffset" : 132,
      "endOffset" : 135
    }, {
      "referenceID" : 8,
      "context" : "Magnetic nanoparticles possess many unique features, such as high biosafety, easy synthesis and outstanding physicochemical properties [10, 11].",
      "startOffset" : 135,
      "endOffset" : 143
    }, {
      "referenceID" : 9,
      "context" : "Magnetic nanoparticles possess many unique features, such as high biosafety, easy synthesis and outstanding physicochemical properties [10, 11].",
      "startOffset" : 135,
      "endOffset" : 143
    }, {
      "referenceID" : 14,
      "context" : "For example, magnetic nanoparticles have been used as imaging contrast agents, radiosensitizers, photothermal treatment agents and so on [16].",
      "startOffset" : 137,
      "endOffset" : 141
    }, {
      "referenceID" : 15,
      "context" : "advantages of composing materials to make it a nearly flawless hybrid material in the application of tumor treatment (figure 1) [17].",
      "startOffset" : 128,
      "endOffset" : 132
    }, {
      "referenceID" : 22,
      "context" : "Sun’s group has lead in the fabrication of dumbbell-shaped Fe3O4–Au nanoparticles [24].",
      "startOffset" : 82,
      "endOffset" : 86
    }, {
      "referenceID" : 23,
      "context" : "Pan et al synthesized the heterodimer Fe3O4–Au MHNs with average diameters of 11–14 nm and heterodimer Fe3O4-Ag (125)I through sequence growth [25, 26].",
      "startOffset" : 143,
      "endOffset" : 151
    }, {
      "referenceID" : 24,
      "context" : "Pan et al synthesized the heterodimer Fe3O4–Au MHNs with average diameters of 11–14 nm and heterodimer Fe3O4-Ag (125)I through sequence growth [25, 26].",
      "startOffset" : 143,
      "endOffset" : 151
    }, {
      "referenceID" : 25,
      "context" : "Xu’s group used a liquid– liquid interface colloidal method to control the sizes of both nanoparticles and functional units to construct the heterodimers [27].",
      "startOffset" : 154,
      "endOffset" : 158
    }, {
      "referenceID" : 26,
      "context" : "Wang’s group synthesized the PEGylated Fe@Fe3O4 core–shell MHNs with no obvious aggregation through separation by outer magnets [28].",
      "startOffset" : 128,
      "endOffset" : 132
    }, {
      "referenceID" : 27,
      "context" : "FePt has such a strong magnetism that the FePt@Fe2O3–PEG MHNs perform the potential application in T2 weighted MRI [29].",
      "startOffset" : 115,
      "endOffset" : 119
    }, {
      "referenceID" : 28,
      "context" : "Pan et al encapsulated platinum nanorods by decomposing Fe(CO)5 to synthesize the Pt@Fe2O3 core–shell MHNs [30].",
      "startOffset" : 107,
      "endOffset" : 111
    }, {
      "referenceID" : 29,
      "context" : "However, the use of PEG can also lead to toxicity [31, 32].",
      "startOffset" : 50,
      "endOffset" : 58
    }, {
      "referenceID" : 30,
      "context" : "However, the use of PEG can also lead to toxicity [31, 32].",
      "startOffset" : 50,
      "endOffset" : 58
    }, {
      "referenceID" : 33,
      "context" : "At present, commonly used imaging techniques in clinical practice [33–35] include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET) [36], single-photon emission computed tomography (SPECT), ultrasound (US), and photoacoustic imaging (PA).",
      "startOffset" : 177,
      "endOffset" : 181
    }, {
      "referenceID" : 34,
      "context" : "which is proven to be a non-invasive and acute rejection detection method [37].",
      "startOffset" : 74,
      "endOffset" : 78
    }, {
      "referenceID" : 24,
      "context" : "Pan et al studied two different structures of Fe3O4–Au nanoparticles, namely the dumbbell-like and the heterodimer Fe3O4–Au nanoparticles [26], which are viewed as a new type of nanometer materials for MRI–CT bimodal imaging.",
      "startOffset" : 138,
      "endOffset" : 142
    }, {
      "referenceID" : 35,
      "context" : "Other than the MHNs mentioned above, Hu’s group focused on the strawberry-like Fe3O4-Au MHNs with enhanced magnetic properties at atmospheric temperature [38].",
      "startOffset" : 154,
      "endOffset" : 158
    }, {
      "referenceID" : 36,
      "context" : "For example, Yu’s group used the FePt-based MHNs for T2-weighted MRI and CT [39].",
      "startOffset" : 76,
      "endOffset" : 80
    }, {
      "referenceID" : 2,
      "context" : "Currently, the common MRI-based trimodal imaging diagnosis methods are MRI/PET/NIFR [4], MRI/PET/SPECT [33], and MRI/PA/ CT [40].",
      "startOffset" : 84,
      "endOffset" : 87
    }, {
      "referenceID" : 31,
      "context" : "Currently, the common MRI-based trimodal imaging diagnosis methods are MRI/PET/NIFR [4], MRI/PET/SPECT [33], and MRI/PA/ CT [40].",
      "startOffset" : 103,
      "endOffset" : 107
    }, {
      "referenceID" : 37,
      "context" : "Currently, the common MRI-based trimodal imaging diagnosis methods are MRI/PET/NIFR [4], MRI/PET/SPECT [33], and MRI/PA/ CT [40].",
      "startOffset" : 124,
      "endOffset" : 128
    }, {
      "referenceID" : 38,
      "context" : "radionuclide imagines such as PET have higher resolution and detection sensitivity, which can make up for the defects of single imaging [41, 42].",
      "startOffset" : 136,
      "endOffset" : 144
    }, {
      "referenceID" : 39,
      "context" : "Notably, Liu’s group used the cation exchange method to synthesize a type of FeSe2-decorated Bi2Se3 nanosheets for a combined strategy including PTT-RT synergistic therapy and MRI/CT/PA/ PET tetramodal imaging (figure 2) [43].",
      "startOffset" : 221,
      "endOffset" : 225
    }, {
      "referenceID" : 40,
      "context" : "Chen’s group prepared a PET–NIFR–MRI trimodal imaging probe by using the Fe3O4-based MHNs [44].",
      "startOffset" : 90,
      "endOffset" : 94
    }, {
      "referenceID" : 41,
      "context" : "Kang’s group has made great efforts to fabricate a novel ‘All-in-One’ MHNs@PES-Cy7/2-DG for trimodal imaging-guided PTT– magnetic hyperthermia therapy (MHT) to achieve outstanding therapeutic performance [45].",
      "startOffset" : 204,
      "endOffset" : 208
    }, {
      "referenceID" : 42,
      "context" : "Hyperthermia therapy has been widely used in clinical cancer therapy for a long time [46].",
      "startOffset" : 85,
      "endOffset" : 89
    }, {
      "referenceID" : 46,
      "context" : "For example, Tay et al combined the MHT with a new imaging modality, magnetic particle imaging (MPI), to realize the image-guided treatment with considerable precision [50].",
      "startOffset" : 168,
      "endOffset" : 172
    }, {
      "referenceID" : 50,
      "context" : "Yang’s group fabricated a multifunctional PEGylated Fe@Fe3O4 MHNs to meet the basic preconditions of PTT [54].",
      "startOffset" : 105,
      "endOffset" : 109
    }, {
      "referenceID" : 51,
      "context" : "To monitor the process and performance of treatment, Li et al synthesized an effective magnetic theranostic nanoplatform (iron oxide-based nanoparticles IONC@Au-PEG) [55].",
      "startOffset" : 166,
      "endOffset" : 170
    }, {
      "referenceID" : 52,
      "context" : "For example, Fu et al synthesized the GO–IONP–PEG NPs with the guidance of diffusion weighted MRI to enhance the PTT effects [56].",
      "startOffset" : 125,
      "endOffset" : 129
    }, {
      "referenceID" : 53,
      "context" : "Wu et al prepared a rattle-type Fe3O4@CuS NPs for imaged-guided PTT at both the first (808 nm) and second (1064 nm) NIR windows [58].",
      "startOffset" : 128,
      "endOffset" : 132
    }, {
      "referenceID" : 54,
      "context" : "Chen’s group reported a synergistic combination of MHT and PTT under the guidance of MRI with core–shell MnFe2O4/PB MHNs [59].",
      "startOffset" : 121,
      "endOffset" : 125
    }, {
      "referenceID" : 37,
      "context" : "It is one of the most effective treatments which are commonly used for malignant tumors in clinical practice [40].",
      "startOffset" : 109,
      "endOffset" : 113
    }, {
      "referenceID" : 55,
      "context" : "large side effects on healthy tissues, and particularly strong radiation resistance of tumor cells [60].",
      "startOffset" : 99,
      "endOffset" : 103
    }, {
      "referenceID" : 38,
      "context" : "Therefore, multifunctional nanomaterials are able to selectively kill cytotoxic cells, regulate cell pathways, and increase cell radiation sensitivity [41, 42, 61].",
      "startOffset" : 151,
      "endOffset" : 163
    }, {
      "referenceID" : 56,
      "context" : "Therefore, multifunctional nanomaterials are able to selectively kill cytotoxic cells, regulate cell pathways, and increase cell radiation sensitivity [41, 42, 61].",
      "startOffset" : 151,
      "endOffset" : 163
    }, {
      "referenceID" : 57,
      "context" : "Pan et al fabricated multifunctional PEGylated Fe@Bi2S3 nanoparticles for bimodal imaging-guided synergistic thermoradiotherapy (figure 3) [62].",
      "startOffset" : 139,
      "endOffset" : 143
    }, {
      "referenceID" : 58,
      "context" : "Multifunctional MHNs with comprehensive diagnostic and therapeutic purposes are widely used in the theranostic treatments [63].",
      "startOffset" : 122,
      "endOffset" : 126
    }, {
      "referenceID" : 3,
      "context" : "The Fe3O4@MSNs with high biocompatibility, good enzyme responsiveness and selectivity can realize the controlled drug release, chemotherapy and MRI-guided diagnosis [5].",
      "startOffset" : 165,
      "endOffset" : 168
    }, {
      "referenceID" : 57,
      "context" : "Reproduced from [62] with permission of The Royal Society of Chemistry.",
      "startOffset" : 16,
      "endOffset" : 20
    }, {
      "referenceID" : 58,
      "context" : "gistic effect of thermoradiotherapy and the guidance of the T2-weighted MRI [63].",
      "startOffset" : 76,
      "endOffset" : 80
    }, {
      "referenceID" : 59,
      "context" : "Pan et al synthesized the PEGylated Au@Pt nanodendrites to enhance the absorption of the first NIR windows (808 nm wavelength) [64].",
      "startOffset" : 127,
      "endOffset" : 131
    }, {
      "referenceID" : 60,
      "context" : "used manganese dioxide coated WS2@Fe3O4/sSiO2 in response to pH-responsive MRI to integrate PTT and RT in the cancer synergistic treatment [65].",
      "startOffset" : 139,
      "endOffset" : 143
    }, {
      "referenceID" : 61,
      "context" : "imaging-guided photothermal enhanced photodynamic therapy (figure 5) [66].",
      "startOffset" : 69,
      "endOffset" : 73
    }, {
      "referenceID" : 62,
      "context" : "Meanwhile, the carefully-prepared of hollow porous iron oxide nanoparticles (PIONs) as theranostic nanoagents for T2-weighted MRI and photothermal/chemotherapy has been reported by Pan et al [67].",
      "startOffset" : 191,
      "endOffset" : 195
    } ],
    "year" : 2018,
    "abstractText" : "Cancer is a major disease that seriously threatens human health and is a leading cause of human death. At present, the commonly used cancer treatment methods are surgical therapy, chemical drug therapy and radiation therapy (RT). However, these treatments all have their own shortcomings and cannot perfectly meet the needs of clinical diagnosis and treatment. It is of great significance to improve the diagnosis and treatment level, so that the curative effect and quality of life of tumor patients can be improved. The rapid development of nanotechnology has brought hope to the diagnosis and treatment of cancer and the appearance of biofunctional magnetic hybrid nanomaterials (MHNs) has provided a new possibilities for the integration of cancer diagnosis and treatment. As a promising research direction, the multifunctional nanoplatform integrates imaging diagnosis, drug therapy and drug delivery. Better treatment effects and fewer side effects can be achieved by optimizing materials to build stable, efficient, and safe MHNs with combined functions of multimodal imaging and various treatments. This review focuses on not only the research progress of MHNs but also their applications and development trend in the integration of cancer diagnosis and treatment. A description of the applications of MHN structure optimization for both magnetic resonance imaging-based multimodal diagnosis and cancer therapy is given. Furthermore, RT is introduced and the development of MHNs for diagnosis and treatment system is investigated.",
    "creator" : "IOPP"
  }
}